The present invention relates to quinoxalinone derivatives of formula (I), wherein R1, R2, R3, R4, R5 and R6 are as defined in claim
1,
as insulin secretion stimulators. The invention also relates to the preparation and use of these quinoxalinone derivatives for the prophylaxis and/or treatment of diabetes and pathologies associated.
Other preferred compounds are compounds of general formula (I), wherein R1, R2, R3, R4, R5 and R6 can be optionally substituted by one or more groups selected from Z;
本发明涉及公式(I)的
喹喔啉酮衍
生物,其中R1、R2、R3、R4、R5和R6如权利要求1所定义,作为
胰岛素分泌刺激剂。该发明还涉及这些
喹喔啉酮衍
生物的制备和用途,用于预防和/或治疗糖尿病和相关病理。其他首选化合物是一般式(I)的化合物,其中R1、R2、R3、R4、R5和R6可以选择地被一个或多个从Z中选择的基取代。